The Antidiabetic Armamentarium: Reducing the Residual Cardiovascular Risk with HbA<sub>1c(v)</sub>-Lowering Medications : Editorial to: "GLP-1 Receptor Agonists and Cardiovascular Disease: A Meta-Analysis of Recent Cardiac Outcome Trials" by Jia X, Alam M, Ye Y et al.

Cardiovasc Drugs Ther · 2018

Last updated 2026-05-28

Journal	Cardiovasc Drugs Ther, 2018
Citations	1
Relative citation ratio	0.04
NIH percentile	4
Molecules	—
Conditions studied	Type 2 Diabetes, Cardiovascular Risk Reduction

Full record and abstract on PubMed 29455345 ↗